![[Hii] COBR slides for 31 October press conference Chief Scientific Advisor cites REACT-1 estimates of daily incidence which was informed by the SAGE meeting of 29 October .pdf](/uploads/r/null/1/b/1/1b126184c148b677b347f4a8a1ab37e29ccb9374187e2705a886b6e6ae638f0d/b8306837-3d1a-4e8a-8046-50024b61fca2-_Hii__COBR_slides_for_31_October_press_conference_Chief_Scientific_Advisor_cites_REACT-1_estimates_of_daily_incidence_which_was_informed_by_the_SAGE_meeting_of_29_October__142.jpg)
590 results with digital objects
Show results with digital objects
![[Hii] IOTA-ADNEX.pdf](/uploads/r/null/7/4/f/74f89afe143d830bf1278d2ea55c582d3822c70ebc6cfde1e56839b5715cd573/e504c745-9f83-4064-8539-fd34d217188e-_Hii__IOTA-ADNEX_142.jpg)
Item
Part of UoA 1
![[Hii] Key Opinion Leaders and Rehabilitation Centres.pdf](/uploads/r/null/4/f/1/4f1c52d510d5675024c6fb049e5a8d7cbe007e2b4d63908a10830ce5f672e5b3/27642ce1-b683-4da2-af04-37086401c8ba-_Hii__Key_Opinion_Leaders_and_Rehabilitation_Centres_142.jpg)
![[Hiii] Key Opinion Leaders and Rehabilitation Centres Amazing Brains 2019 Professor Jane Burridge - Technology For Stroke Recovery Are We Nearly There.pdf](/uploads/r/null/3/d/a/3da018f83fa064241dbc127a28cbd91add7ba894ff6de8d8521b41dfa38ee0ac/c9785e32-60ed-4d80-b747-60b2eeca8592-_Hiii__Key_Opinion_Leaders_and_Rehabilitation_Centres_Amazing_Brains_2019_Professor_Jane_Burridge_-_Technology_For_Stroke_Recovery_Are_We_Nearly_There_142.jpg)
![[I] ADNEX risk model.pdf](/uploads/r/null/4/9/0/490ac1e578d19013c3c2e4ec28ab37c85e6385e74e3e30ba118ed5fe346b5777/dacf8216-6e29-4371-a8bd-e4816004efd7-_I__ADNEX_risk_model_142.jpg)
Item
Part of UoA 1
![[I] Article by the Herald Sun on 27 March 2015 about the purchase of Dr Foster by Telstra](/uploads/r/null/4/6/4/464b775866848144c3750bcff8fed97690f41bbe1a047726c24adc0eb9c72c04/d50de50d-abf1-4fcc-b207-f4021905888a-_I__Telstra__Dr_Foster_purchase_142.jpg)
Item
·
27 March 2015
Part of UoA 10
Article by the Herald Sun on 27 March 2015 about the purchase of Dr Foster by Telstra
Hearld Sun![[I] Baseline report: Smallholder impact evaluation of maize value chain development in Tanzania. The World Bank Group and Let's Work Tanzania.](/uploads/r/null/c/2/9/c2905e3a4bc60c6eda7f4a9a6e364e02b3495272502e5d4eeab02e4bd464328b/b3280cef-4c91-46e2-8ebf-3401a3825d7d-i-jv-lc-impact-evaluation-maize-vc-tanzania_142.jpg)
Item
·
2018
Part of UoA 14
Baseline report: Smallholder impact evaluation of maize value chain development in Tanzania. The World Bank Group and Let's Work Tanzania.
Vandercasteleen, J., and L. Christiaensen![[I] Best Practices in Child and Adolescent TB Care.pdf](/uploads/r/null/7/a/e/7ae3332acb450662fdb56da88a8dc9fad3daec705dafb6c92f9012e26fa8ac69/959f42f8-08b5-476d-9ad1-7d30978fd5b0-_I__Best_Practices_in_Child_and_Adolescent_TB_Care_142.jpg)
![[I] BioMin receives FDA Approval](/uploads/r/null/e/0/d/e0d10257e5ce4513c24779a688d480921b2a63732d8c13cba6b66e4e807038e6/da5393f2-0a6e-42d0-8c99-528523bf89cf-_I__screencapture-markets-businessinsider-news-stocks-dr-collins-biomin-toothpaste-receives-fda-approval-1028470492-2021-03-05-09_24_47_142.jpg)
Item
·
23/8/2019
Part of UoA 8
Press release stating that Dr.Collins BioMin Toothpaste Receives FDA Approval
PRNewswire-PRWeb![[I] Cleaner air for Scotland strategy.pdf](/uploads/r/null/6/8/8/68876d01af17e182801820ebbbd6a25a8749f2d797367ceee626261a479e4e99/d0496704-02e3-441d-9a85-1cbb7070ac3f-_I__Cleaner_air_for_Scotland_strategy_142.jpg)
Item
Part of UoA 2
![[I] EMA Summary of opinion Kalydeco.pdf](/uploads/r/null/6/9/f/69f5b6684c69eaf2ab9e4e024465979536dc4a61a3e03362c92a9472a7406f5e/77efc402-d85b-4c97-9d44-b53f7a027c7e-_I__EMA_Summary_of_opinion_Kalydeco_142.jpg)
Item
Part of UoA 1
![[I] Evonik press release on strategic importance of Alkion BioPharma to its business](/uploads/r/null/6/8/a/68a773de2f05cb50f88c7ee17c34ca17f3ed9b7bd10a4cbb45c4517ff5a10082/723aecac-48d9-4193-90bb-af3c732ffedc-_I__evonik-en-quantum-leap-in-tours-2021-02-02-13_24_37_142.jpg)
Item
Part of UoA 5
Evonik press release on strategic importance of Alkion BioPharma to its business
Evonik![[I] Evotec Partnered Drug Discovery and Development](/uploads/r/null/1/e/2/1e212d9538459860906f8031c85645193d90ba79f8a7e41367f0fd2e6d0ff2ca/1b81052e-6d69-4cf0-867c-91a0648f85d6-_I__Evotec_SE_142.jpg)
![[I] Exotic species threaten local wildlife](/uploads/r/null/4/0/7/4075ee62b46a1f7a8a1208a64b7b5f23dc51618992d8fcbbfb45f25f1e8411cc/8da3c91d-717a-42c1-a437-c509efee3fcf-_I__screencapture-unboxingdiseases-eu-exotic-species-html-2021-02-04-12_07_25_142.jpg)
Item
Part of UoA 5
Bsal and Bd idenitifed as a threat to local wildlife from exotic species.
Unboxingdiseases![[I] Guidance Framework for Testing the Sterile Insect Technique as a Vector Control Toolagainst Aedes-Borne Diseases](/uploads/r/null/3/c/6/3c60ef2c7a6e9b4cb5ce8185ea747cabc8a97a23dd6e9804bb031ecae40203fc/ee249603-51b2-4c33-9bef-f7a5b69cc7b1-_I__WHO_IAEA_2020_142.jpg)
Item
·
April 2020
Part of UoA 14
Guidance Framework for Testing the Sterile Insect Technique as a Vector Control Toolagainst Aedes-Borne Diseases
WHO & IAEA![[I] influence-on-policy-reports-on-ebola](/uploads/r/null/b/c/d/bcd0f50cb6b2f8d58c0d05f21543ec4eb8730f3f3dfb61318a222f0241c90750/30566fb4-21c1-4111-838c-8bf399e5f26e-_I__webarchive-nationalarchives-gov-uk-20200923120436-https-mrc-ukri-org-news-browse-influence-on-policy-reports-on-ebola-2021-02-01-12_30_15_142.jpg)
Item
Part of SPH0003
![[I] Letter from Secretary of State approving the London Plan](/uploads/r/null/7/5/4/7543e0d0f94983b3e5ef163b8cae5cfe78f448e7ce6dc2ba3fe65dd1c9c6853e/ed8b53ed-5128-43f2-a853-514bc3ad355b-_I__letter_from_sos_mhclg_london_plan_29_jan_21_142.jpg)
Item
·
December 2020
Part of UoA 8
Letter from Secretary of State approving the London Plan
![[I] Miscarriage, ectopic pregnancy and molar pregnancy.pdf](/uploads/r/null/9/5/9/9592058d0844d6d1dfa3be2524bed4ae1e048ca424ce30aff54cca328bd389f6/3555cbe0-5935-4507-b5a1-74d8970f0197-_I__Miscarriage__ectopic_pregnancy_and_molar_pregnancy_142.jpg)
![[I] Monitor Improving GP services commissioners and patient choice June 2015.pdf](/uploads/r/null/e/f/a/efab987b4fda1bf29d934cfc19962c1691592aecca0a7a6a1c0dd05ca5fad40a/32ac5dc0-1627-4075-8377-d3615d30bf7d-_I__Monitor_Improving_GP_services_commissioners_and_patient_choice_June_2015_142.jpg)
![[I] Paper detailing the results of the Phase 2 trails](/uploads/r/null/8/2/4/824c87a82dfed7423bc972ac3dca73c55575ae1c0334c529c2fa3355d8ac1abd/292fb6dd-5246-4f6f-97e3-7a4434368069-_I__Laitio_2016_142.jpg)
Item
·
15/3/2016
Part of UoA 5
Phase 2 trials results